Biolytx Pharmaceuticals
Oklahoma City, US · Delaware corporation
Founders & leadership
DA
Douglas A BranchExecutive
HA
H Anne PereiraNamed on SEC filing
Board
WA
William A HagstromBoard director
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2015
▶$1.3MraisedOct 2015 · 12 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedOct 2015 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A BranchExecutive Officer
- William A HagstromDirector
- H Anne PereiraExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- Proceeds to insiders
- $16K
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Biolytx Pharmaceuticals raised?
- Biolytx Pharmaceuticals has disclosed $1.3M raised across 1 round.
- Where is Biolytx Pharmaceuticals headquartered?
- Biolytx Pharmaceuticals is headquartered in Oklahoma City, US.